Literature DB >> 3552329

Coeliac disease: a critical review of aetiology and pathogenesis.

A G Davidson, M A Bridges.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3552329     DOI: 10.1016/0009-8981(87)90031-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  8 in total

Review 1.  Molecular biology and coeliac disease.

Authors:  P D Howdle; G E Blair
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

2.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

3.  Natural killer cell activity in coeliac disease: effect of in vitro treatment on effector lymphocytes and/or target lymphoblastoid, myeloid and epithelial cell lines with gliadin.

Authors:  M A Castany; H H Nguyen; M Pospísil; P Fric; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Screening for celiac disease.

Authors:  A G Davidson; E G Hassall
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

5.  Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease.

Authors:  R B Gallagher; C Feighery; D G Weir; C P Kelly; C A Whelan
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

6.  Mathematical correlation between villus height and the nutritional state in Sprague-Dawley rats.

Authors:  J L Zambonino Infante; J M Rouanet; P Besançon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.

Authors:  S Friis; E Dabelsteen; H Sjöström; O Norén; S Jarnum
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

8.  Antibody response reveal differences in oral tolerance to wheat and maize grain protein fractions.

Authors:  R B Johnson; J T Labrooy; J H Skerritt
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.